Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4475)
All Articles published online
|
Mar 14, 2012 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Diao L, Mei Q, Xu JM, Liu XC, Hu J, Jin J, Yao Q, Chen ML. Rebamipide suppresses diclofenac-induced intestinal permeability |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i10/1059.htm |
| Number | Citing Articles |
| 1 |
Kyu‐Man Cho, Seon‐Young Park, Jin Ook Chung, Chung‐Hwan Jun, Tae‐Jong Kim, Dong‐Jun Son, Ban‐Suk Kim, Chang‐Hwan Park, Hyun‐Soo Kim, Sung‐Kyu Choi, Jong‐Sun Rew. Risk factors for small bowel bleeding in chronic nonsteroidal anti‐inflammatory drug users. Journal of Digestive Diseases 2015; 16(9): 499 doi: 10.1111/1751-2980.12269
|
| 2 |
D. A. Kashtanova, O. N. Tkacheva. The phenomenon of intestinal permeability and its association with cardiovascular disease. Current status. Cardiovascular Therapy and Prevention 2020; 19(3): 2474 doi: 10.15829/1728-8800-2020-2474
|
| 3 |
Sarah M. R. Cosyns, Leander Huyghe, Robrecht Thoonen, Johannes‐Peter Stasch, Peter Brouckaert, Romain A. Lefebvre. Influence of cinaciguat on gastrointestinal motility in apo‐sGC mice. Neurogastroenterology & Motility 2014; 26(11): 1573 doi: 10.1111/nmo.12424
|
| 4 |
Satoshi Kondo, Shota Mizuno, Tadahiro Hashita, Takahiro Iwao, Tamihide Matsunaga. Using human iPS cell-derived enterocytes as novel in vitro model for the evaluation of human intestinal mucosal damage. Inflammation Research 2018; 67(11-12): 975 doi: 10.1007/s00011-018-1193-0
|
| 5 |
Abdallah M. Gendy, Dalaal M. Abdallah, Hanan S. El-Abhar. The potential curative effect of rebamipide in hepatic ischemia/reperfusion injury. Naunyn-Schmiedeberg's Archives of Pharmacology 2017; 390(7): 691 doi: 10.1007/s00210-017-1370-7
|
| 6 |
Toru Imai, Katsuyuki Hazama, Yasuhiro Kosuge, Shinichiro Suzuki, Susumu Ootsuka. Preventive effect of rebamipide on NSAID-induced lower gastrointestinal tract injury using FAERS and JADER. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-06611-y
|
| 7 |
Akanksha Mishra, Sairam Krishnamurthy. Rebamipide Mitigates Impairments in Mitochondrial Function and Bioenergetics with α-Synuclein Pathology in 6-OHDA-Induced Hemiparkinson’s Model in Rats. Neurotoxicity Research 2019; 35(3): 542 doi: 10.1007/s12640-018-9983-2
|
| 8 |
Jan Martel, Shih-Hsin Chang, Yun-Fei Ko, Tsong-Long Hwang, John D. Young, David M. Ojcius. Gut barrier disruption and chronic disease. Trends in Endocrinology & Metabolism 2022; 33(4): 247 doi: 10.1016/j.tem.2022.01.002
|
| 9 |
Dong Jun Oh, Hyuk Yoon, Hyun Soo Kim, Yoon Jin Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, You-Jung Ha, Eun Ha Kang, Yun Jong Lee, Nayoung Kim, Ki-Jeoung Kim, Fei Liu. The effect of rebamipide on non-steroidal anti-inflammatory drug-induced gastro-enteropathy: a multi-center, randomized pilot study. The Korean Journal of Internal Medicine 2022; 37(6): 1153 doi: 10.3904/kjim.2021.216
|
| 10 |
Dong Shin Kwak, Oh Young Lee, Kang Nyeong Lee, Dae Won Jun, Hang Lak Lee, Byung Chul Yoon, Ho Soon Choi. The Effect of DA-6034 on Intestinal Permeability in an Indomethacin-Induced Small Intestinal Injury Model. Gut and Liver 2016; 10(3) doi: 10.5009/gnl15251
|
| 11 |
Ning Xu, Cuiping Zhang, Lili Jing, Shaojiao Mou, Xiaoling Cao, Zhenhai Yu. Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injury. International Immunopharmacology 2021; 90: 107136 doi: 10.1016/j.intimp.2020.107136
|
| 12 |
A.T. Sougiannis, B.N. VanderVeen, R.T. Enos, K.T. Velazquez, J.E. Bader, M. Carson, I. Chatzistamou, M. Walla, M.M. Pena, J.L. Kubinak, M. Nagarkatti, J.A. Carson, E.A. Murphy. Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota. Brain, Behavior, and Immunity 2019; 80: 44 doi: 10.1016/j.bbi.2019.02.020
|
| 13 |
A. I. Martynov, A. A. Sheptulin, I. V. Mayev, A. N. Kazyulin, A. Ye. Karateev, A. V. Melekhov, L. K. Pal’gova, K. L. Raikhel’son. New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review). Russian Journal of Gastroenterology, Hepatology, Coloproctology 2020; 30(2): 7 doi: 10.22416/1382-4376-2020-30-2-7-14
|
| 14 |
Jong M. Park, Ho J. Lee, Predrag Sikiric, Ki B. Hahm. BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection. Current Pharmaceutical Design 2020; 26(25): 2971 doi: 10.2174/1381612826666200523180301
|
| 15 |
Matteo Fornai, Luca Antonioli, Rocchina Colucci, Carolina Pellegrini, Giulio Giustarini, Lara Testai, Alma Martelli, Antuela Matarangasi, Gianfranco Natale, Vincenzo Calderone, Marco Tuccori, Carmelo Scarpignato, Corrado Blandizzi. NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same?. Journal of Pharmacology and Experimental Therapeutics 2014; 348(1): 86 doi: 10.1124/jpet.113.207118
|
| 16 |
Gunuputi Sushma, Bhupesh Vaidya, Shikha Sharma, Geetanjali Devabattula, Mahendra Bishnoi, Kanthi Kiran Kondepudi, Shyam S. Sharma. Bifidobacterium breve Bif11 supplementation improves depression-related neurobehavioural and neuroinflammatory changes in the mouse. Neuropharmacology 2023; 229: 109480 doi: 10.1016/j.neuropharm.2023.109480
|
| 17 |
Yijun Cheng, Yongxu Wei, Wenlei Yang, Yu Cai, Bin Chen, Guoyuan Yang, Hanbing Shang, Weiguo Zhao. Ghrelin Attenuates Intestinal Barrier Dysfunction Following Intracerebral Hemorrhage in Mice. International Journal of Molecular Sciences 2016; 17(12): 2032 doi: 10.3390/ijms17122032
|
| 18 |
Damian Maseda, Emanuela Ricciotti. NSAID–Gut Microbiota Interactions. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01153
|
| 19 |
Yasuhito Funahashi, Masaki Yoshida, Tokunori Yamamoto, Tsuyoshi Majima, Shun Takai, Momokazu Gotoh. Intravesical Application of Rebamipide Suppresses Bladder Inflammation in a Rat Cystitis Model. Journal of Urology 2014; 191(4): 1147 doi: 10.1016/j.juro.2013.11.026
|
| 20 |
Zhuoran Han, Lunhua Ge, Siyi Wen, Jingfeng Sun. Dysfunction of the intestinal physical barrier in the intestinal inflammation of tongue sole, Cynoglossus semilaevis, induced by Shewanella algae infection. Fish & Shellfish Immunology 2023; 139: 108900 doi: 10.1016/j.fsi.2023.108900
|
| 21 |
E. Pinto, K. Hrimpeng, G. Lopes, S. Vaz, M. J. Gonçalves, C. Cavaleiro, L. Salgueiro. Antifungal activity of Ferulago capillaris essential oil against Candida, Cryptococcus, Aspergillus and dermatophyte species. European Journal of Clinical Microbiology & Infectious Diseases 2013; 32(10): 1311 doi: 10.1007/s10096-013-1881-1
|
| 22 |
Takahiro Iwao, Tamihide Matsunaga. Intestinal cells differentiated from human induced pluripotent stem cells for use in drug development studies. Translational and Regulatory Sciences 2019; 1(1): 24 doi: 10.33611/trs.1_24
|
| 23 |
Sherin Zakaria, Alaa El-Sisi. Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2. Journal of Immunotoxicology 2016; 13(4): 453 doi: 10.3109/1547691X.2015.1128022
|
| 24 |
Cheng Yang, Mei-Hua Cui. NSAID-induced small intestinal mucosal injury: Mechanism, prevention and treatment. World Chinese Journal of Digestology 2019; 27(6): 347 doi: 10.11569/wcjd.v27.i6.347
|
| 25 |
Peter R. Kvietys, Ahmed Yaqinuddin, Wael Al Kattan. Gastrointestinal Mucosal Defense System. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2014; 6(5): 1 doi: 10.4199/C00119ED1V01Y201409ISP058
|
| 26 |
Dustin L. Cooper, Robert C. Wood, Jarrett E. Wyatt, Sam Harirforoosh. Pharmacokinetic interactions between rebamipide and selected nonsteroidal anti-inflammatory drugs in rats. European Journal of Pharmaceutical Sciences 2014; 53: 28 doi: 10.1016/j.ejps.2013.12.002
|